Liquidia Co. (NASDAQ:LQDA) Shares Acquired by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.

Posted by Defense World Staff on Aug 12th, 2023

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its holdings in shares of Liquidia Co. (NASDAQ:LQDA – Free Report) by 2.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 554,822 shares of the company’s stock after acquiring an additional 14,757 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. owned approximately 0.86% of Liquidia worth $3,834,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of LQDA. UBS Group AG lifted its stake in Liquidia by 134.0% during the 2nd quarter. UBS Group AG now owns 7,948 shares of the company’s stock valued at $35,000 after acquiring an additional 4,552 shares during the period. Legal & General Group Plc acquired a new stake in Liquidia during the 2nd quarter valued at approximately $38,000. BNP Paribas Arbitrage SA lifted its stake in Liquidia by 42.8% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 10,682 shares of the company’s stock valued at $47,000 after acquiring an additional 3,200 shares during the period. Virtu Financial LLC acquired a new stake in Liquidia during the 2nd quarter valued at approximately $82,000. Finally, Barclays PLC lifted its stake in Liquidia by 511.7% during the 4th quarter. Barclays PLC now owns 12,900 shares of the company’s stock valued at $82,000 after acquiring an additional 10,791 shares during the period. 45.50% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. BTIG Research decreased their price objective on shares of Liquidia from $20.00 to $18.00 in a research note on Thursday, July 6th. HC Wainwright reaffirmed a “buy” rating and set a $16.00 target price on shares of Liquidia in a report on Friday. Wedbush reaffirmed an “underperform” rating and set a $3.00 target price on shares of Liquidia in a report on Friday, June 30th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $18.00 target price on shares of Liquidia in a report on Thursday.

Check Out Our Latest Stock Report on LQDA

Liquidia Price Performance

NASDAQ:LQDA opened at $7.17 on Friday. The firm has a market cap of $464.04 million, a price-to-earnings ratio of -12.80 and a beta of 0.06. The company has a 50 day moving average price of $8.13 and a 200-day moving average price of $7.50. Liquidia Co. has a 1-year low of $4.06 and a 1-year high of $9.95.

Liquidia Company Profile

(Free Report)

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension.